Business Trip
En podcast av Greg Kubin & Matias Serebrinsky - Torsdagar
59 Avsnitt
-
Holy poop! Mental health and the gut (part 2 with Bloom Science)
Publicerades: 2023-09-28 -
Holy poop! Mental health and the gut (part 1 with Holobiome)
Publicerades: 2023-09-14 -
Ketamine for OCD: Carolyn Rodriguez (Stanford pt 3)
Publicerades: 2023-08-24 -
Are psychedelics effective under anesthesia?: Boris Heifets (Stanford pt 2)
Publicerades: 2023-08-17 -
The Startup Landscape for Expanding Consciousness
Publicerades: 2023-08-09 -
Stanford Psychedelic Overview: Robert Malenka (Stanford pt 1)
Publicerades: 2023-07-20 -
Live from Psychedelic Science 2023
Publicerades: 2023-07-07 -
What VCs Look for in Psychedelic Companies
Publicerades: 2023-06-09 -
Developing Non-Hallucinogenic Psychedelics: Bryan Roth
Publicerades: 2023-05-15 -
Behind the Scenes of PsyMed Ventures
Publicerades: 2023-04-14 -
The 2023 Psychedelic Industry Landscape with Psychedelic Alpha
Publicerades: 2023-02-27 -
The State of Psychedelics (Part 2): Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House)
Publicerades: 2023-01-18 -
The quest to improve MDMA
Publicerades: 2022-12-20 -
Transcranial magnetic stimulation (TMS) paired with ketamine: inside a clinic offering a frontier treatment
Publicerades: 2022-11-29 -
Perspectives from Christian Angermayer, investor and founder in psychedelics
Publicerades: 2022-10-27 -
Soltara: an ethical and profitable ayahuasca retreat
Publicerades: 2022-09-14 -
Microdosing (part 3): The path to FDA approval w/ MindMed and Diamond Therapeutics
Publicerades: 2022-08-16 -
Microdosing (part 2): Placebo is a hell of a drug with Balázs Szigeti
Publicerades: 2022-08-10 -
Microdosing (part 1): James Fadiman and the fundamentals of microdosing
Publicerades: 2022-08-03 -
How the DEA and FDA will regulate psychedelic medicine
Publicerades: 2022-06-24
Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more.
